Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1985 1
1987 1
1989 1
2009 1
2010 1
2011 4
2012 13
2013 14
2014 16
2015 11
2016 12
2017 12
2018 14
2019 19
2020 17
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Results by year
Filters applied: . Clear all
Page 1
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group. Fervenza FC, et al. Among authors: eirin a. Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12. Nephron. 2015. PMID: 26087670 Clinical Trial.
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M, Irazabal MV, Eirin A, Zand L, Sethi S, Borah BJ, Winters JL, Moriarty JP, Cartin-Ceba R, Berti A, Baqir M, Thompson GE, Makol A, Warrington KJ, Thao V, Specks U, Fervenza FC. Casal Moura M, et al. Among authors: eirin a. J Am Soc Nephrol. 2020 Nov;31(11):2688-2704. doi: 10.1681/ASN.2019111197. Epub 2020 Aug 21. J Am Soc Nephrol. 2020. PMID: 32826324
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.
Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC; Mayo Nephrology Collaborative Group. Fervenza FC, et al. Among authors: eirin a. Clin J Am Soc Nephrol. 2010 Dec;5(12):2188-98. doi: 10.2215/CJN.05080610. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705965 Free PMC article.
Novel therapeutic strategies for renovascular disease.
Eirin A, Textor SC, Lerman LO. Eirin A, et al. Curr Opin Nephrol Hypertens. 2019 Jul;28(4):383-389. doi: 10.1097/MNH.0000000000000513. Curr Opin Nephrol Hypertens. 2019. PMID: 31045658 Free PMC article. Review.
Emerging Paradigms in Chronic Kidney Ischemia.
Eirin A, Textor SC, Lerman LO. Eirin A, et al. Hypertension. 2018 Nov;72(5):1023-1030. doi: 10.1161/HYPERTENSIONAHA.118.11082. Hypertension. 2018. PMID: 30354824 Free PMC article. Review. No abstract available.
Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.
Bian X, Griffin TP, Zhu X, Islam MN, Conley SM, Eirin A, Tang H, O'Shea PM, Palmer AK, McCoy RG, Herrmann SM, Mehta RA, Woollard JR, Rule AD, Kirkland JL, Tchkonia T, Textor SC, Griffin MD, Lerman LO, Hickson LJ. Bian X, et al. Among authors: eirin a. BMJ Open Diabetes Res Care. 2019 Dec 15;7(1):e000720. doi: 10.1136/bmjdrc-2019-000720. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31908790 Free PMC article.
Enhancing Mitochondrial Health to Treat Hypertension.
Eirin A, Lerman A, Lerman LO. Eirin A, et al. Curr Hypertens Rep. 2018 Aug 17;20(10):89. doi: 10.1007/s11906-018-0889-4. Curr Hypertens Rep. 2018. PMID: 30120623 Free PMC article. Review.
128 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page